Skip to main content

Table 7 Estimated Percentage of BMS and CABG Patients who Should Receive DES by Year Following DES Approval*

From: Changing treatment patterns for coronary artery revascularization in Canada: the projected impact of drug eluting stents

 

Mean

Median

Min

Max

% of Patients Who Should Receive DES, 1st Year Following Approval

Bare metal stent patients

42.8%

30.0%

5.1%

100.0%

CABG patients

16.8%

10.0%

5.0%

50.0%

% of Patients Who Should Receive DES, 2nd Year Following Approval

Bare metal stent patients

56.0%

50.0%

10.2%

100.0%

CABG patients

25.5%

20.0%

5.0%

80.0%

% of Patients Who Should Receive DES, 3rd Year Following Approval

Bare metal stent patients

70.1%

90.0%

30.0%

100.0%

CABG patients

31.4%

30.0%

5.0%

90.0%

% of Patients Who Should Receive DES, 4th Year Following Approval

Bare metal stent patients

79.7%

90.0%

40.6%

100.0%

CABG patients

37.8%

35.0%

5.0%

90.0%

% of Patients Who Should Receive DES, 5th Year Following Approval

Bare metal stent patients

86.8%

90.0%

60.8%

100.0%

CABG patients

43.7%

40.0%

5.0%

90.0%

  1. *In answering this question, respondents were asked to assume that funding for DES was available. All questions were responded to by all 11 members of the study panel.